15 Recruiting Idiopathic Pulmonary Fibrosis Phase 2 Clinical Trials
Active phase 2 studies for idiopathic pulmonary fibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Idiopathic Pulmonary Fibrosis studiesPhase 2 Studies for Idiopathic Pulmonary Fibrosis
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
📍 Research Site — Quilmes, Buenos Aires
View Study & Checklist ➔LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
📍 Royal Prince Alfred Hospital — Camperdown, New South Wales
View Study & Checklist ➔Xenon MRI and Progressive ILD
📍 Duke University — Durham, North Carolina
View Study & Checklist ➔A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
📍 Keck School of Medicine at USC — Los Angeles, California
View Study & Checklist ➔Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
📍 Pulmonary Associates, PA — Mesa, Arizona
View Study & Checklist ➔Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
📍 Trial Management Group Inc — Windsor, Ontario
View Study & Checklist ➔Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
📍 UPMC Presbyterian — Pittsburgh, Pennsylvania
View Study & Checklist ➔Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
📍 Instituto Ave Pulmo — Mar del Plata, Buenos Aires
View Study & Checklist ➔Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
📍 Cedars-Sinai — Los Angeles, California
View Study & Checklist ➔A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
📍 WISPer Site in Birmingham, AL — Birmingham, Alabama
View Study & Checklist ➔Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
📍 Biosolutions Clinical Research — La Mesa, California
View Study & Checklist ➔Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
📍 The University of Alabama at Birmingham /ID# 277613 — Birmingham, Alabama
View Study & Checklist ➔